CTD-T AM 6.25/40/5 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg)
Overview CTD-T AM 6.25/40/5 Tablet
The combined medication CTD-T AM 6.25/40/5 Tablet is indicated for hypertension management when monotherapy proves insufficient. It effectively reduces elevated blood pressure, thereby mitigating the risk of future cardiovascular events like stroke and heart attack. Administer this tablet with food, following your physician's prescribed dosage regimen for optimal efficacy. Consistent daily intake, as directed by your doctor, is crucial. This formulation includes a diuretic, increasing urination; therefore, avoid dosing within four hours of bedtime. Continuous use, even during symptom-free periods, is vital for sustained blood pressure control. Discontinuing treatment may heighten the risk of stroke or heart attack. Commonly reported side effects encompass ankle edema, cephalalgia, vertigo, fatigue, and altered taste perception. Consult your healthcare provider if any adverse effects persist, worsen, or are bothersome. Maintain adequate hydration to alleviate potential side effects such as muscle weakness, xerostomia, and polydipsia. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical guidance. Complete disclosure of all concurrent medications, particularly those for hypertension or cardiac issues, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is recommended to assess therapeutic efficacy and safety.
Primary Ingredients of CTD-T AM 6.25/40/5 Tablet
No text provided to rephrase.
Uses of CTD-T AM 6.25/40/5 Tablet
Elevated blood pressure
Major Benefits of CTD-T AM 6.25/40/5 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-T AM 6.25/40/5 Tablet should be administered with a meal.
Common Side effects of CTD-T AM 6.25/40/5 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use CTD-T AM 6.25/40/5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-T AM 6.25/40/5 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How CTD-T AM 6.25/40/5 Tablet works:
Each CTD-T AM 6.25/40/5 tablet unites telmisartan (an angiotensin receptor blocker or ARB), amlodipine (a calcium channel blocker or CCB), and chlorthalidone (a diuretic). Telmisartan and amlodipine reduce blood pressure by promoting vasodilation, widening and relaxing blood vessels. Chlorthalidone lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to long-term vascular relaxation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside CTD-T AM 6.25/40/5 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using CTD-T AM 6.25/40/5 Tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known dangers. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of CTD-T AM 6.25/40/5 Tablet during lactation appears to pose minimal risk. Available human data indicate negligible infant hazard associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of CTD-T AM 6.25/40/5 Tablets. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Exercise caution when administering CTD-T AM 6.25/40/5 Tablet to individuals with severely impaired renal function. Dosage modification may be necessary; physician consultation is advised. This medication is contraindicated in patients with such conditions.
LiverCAUTION
Patients with liver impairment should use CTD-T AM 6.25/40/5 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. CTD-T AM 6.25/40/5 Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take CTD-T AM 6.25/40/5 Tablet :
Should you forget to take a CTD-T AM 6.25/40/5 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-T AM 6.25/40/5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





